Gujing Distillery announced its third quarter report today that the company's profit in the first three quarters was RMB 350 million, an increase of 145.4% year-on-year.
According to the three quarterly reports released by Gujing Distillery, the company’s operating income for the first three quarters was 2.237 billion yuan, a year-on-year increase of 79.53%; net profit attributable to shareholders of listed companies was 350 million yuan, an increase of 145.4% year-on-year; and basic earnings per share was 1.48 yuan. .
Gujing Distillery Company stated that the main reason for the change in performance was that during the reporting period, sales of liquor increased, and the increase in operating income was greater than the increase in operating costs. In spite of the significant increase in performance, the accounts receivable of Gujing Distillery increased by a significant 347% as of the end of the reporting period. However, the company's operating cash is sufficient. As of the end of the reporting period, Gujing Distillery held a net amount of 1.893 billion yuan in cash and cash equivalents.
The company explained that the company's cash flow is still significantly increased, mainly due to the company's additional funds raised in place during the reporting period. It is worth mentioning that many investment institutions have extremely high “loyalty†for Gujing Distillery, and the data shows that although the stock index has been down all the way in the three quarterly reports, the top ten shareholders of circulation including several investment funds have held shares. There has been no change in the quantity. The stock also repays these investment institutions with its excellent performance. From July 1 to September 30, Gujing Distillery rose 7.29% in the third quarter, while the Shanghai Composite Index fell sharply over the same period. 14.76%.
According to the three quarterly reports released by Gujing Distillery, the company’s operating income for the first three quarters was 2.237 billion yuan, a year-on-year increase of 79.53%; net profit attributable to shareholders of listed companies was 350 million yuan, an increase of 145.4% year-on-year; and basic earnings per share was 1.48 yuan. .
Gujing Distillery Company stated that the main reason for the change in performance was that during the reporting period, sales of liquor increased, and the increase in operating income was greater than the increase in operating costs. In spite of the significant increase in performance, the accounts receivable of Gujing Distillery increased by a significant 347% as of the end of the reporting period. However, the company's operating cash is sufficient. As of the end of the reporting period, Gujing Distillery held a net amount of 1.893 billion yuan in cash and cash equivalents.
The company explained that the company's cash flow is still significantly increased, mainly due to the company's additional funds raised in place during the reporting period. It is worth mentioning that many investment institutions have extremely high “loyalty†for Gujing Distillery, and the data shows that although the stock index has been down all the way in the three quarterly reports, the top ten shareholders of circulation including several investment funds have held shares. There has been no change in the quantity. The stock also repays these investment institutions with its excellent performance. From July 1 to September 30, Gujing Distillery rose 7.29% in the third quarter, while the Shanghai Composite Index fell sharply over the same period. 14.76%.
Long-standing high blood pressure can cause damage to the small vessels in your body and also cause the heart to thicken and stiffen
Checking your blood pressure can help you and your doctor figure out if you need medications or that your medications are working.
Maintaining a healthy blood pressure is one of the keys to overall health.
Blood Pressure Monitor,Blood Pressure Machine,Best Blood Pressure Monitor,Best Blood Pressure Machine
Ningbo Queen Electronic Science Technology Co., Ltd , https://www.queenmeds.com